APA

Charland S. L., Agatep B. C., Herrera V., Schrader B., Frueh F. W., Ryvkin M., Shabbeer J., Devlin J. J., Superko H. R. & Stanek E. J. (20150105). Providing patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial. : The pharmacogenomics journal.

Chicago

Charland S L, Agatep B C, Herrera V, Schrader B, Frueh F W, Ryvkin M, Shabbeer J, Devlin J J, Superko H R and Stanek E J. 20150105. Providing patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial. : The pharmacogenomics journal.

Harvard

Charland S. L., Agatep B. C., Herrera V., Schrader B., Frueh F. W., Ryvkin M., Shabbeer J., Devlin J. J., Superko H. R. and Stanek E. J. (20150105). Providing patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial. : The pharmacogenomics journal.

MLA

Charland S L, Agatep B C, Herrera V, Schrader B, Frueh F W, Ryvkin M, Shabbeer J, Devlin J J, Superko H R and Stanek E J. Providing patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial. : The pharmacogenomics journal. 20150105.